Merck signs $356M deal to supply US with experimental coronavirus drug
Bio Pharma Dive
DECEMBER 23, 2020
The drugmaker spent $425 million a month ago to acquire the biotech developer of the treatment, which tamps down on the body's inflammatory response to viral infections.
Let's personalize your content